Close
Nordic 9Nordic 9

Bioeconomy Capital (investor - Venture Capital)

United States bioeconomycapital.com
See something wrong or missing? Let us know
Offices:Seattle

Bioeconomy Capital invests in early-stage companies with the goal of accelerating the biotechnology revolution.

Average round investment:9.71M USD
Average number per year:1.0
Distribution: 2017 (1)
Portfolio companies: United Kingdom Synthace
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Bioeconomy Capital

Name Criteria
United States Biospring Partners
88%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
Hungary Granpool Innovative Investments
88%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United Kingdom XTX Ventures
88%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United States Zach Weinberg
88%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
Israel Nadav Rosenberg
88%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United Kingdom University of Bristol Enterprise Fund
88%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
United Kingdom Calculus Capital
88%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
United States 11.2 Capital
87%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
United Kingdom Luminous VC
87%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
Poland Atmos Ventures
87%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
Top